Weiss Multi-Strategy Advisers’s Integra LifeSciences IART Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-11,621	Closed	-$227K	–	1034
2013 Q4	$227K	Buy	+11,621	New	+$213K	﹤0.01%	877

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Weiss Multi-Strategy Advisers's IART Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Integra LifeSciences (IART) in Q1 2014, closing a stake of 11,621 shares — an estimated $227K sold.

Weiss Multi-Strategy Advisers first reported a position in IART in Q4 2013 and held it in 1 quarter. The position peaked at $227K in Q4 2013. 144 funds tracked by Wall St. Rank hold IART as of Q1 2014.

Weiss Multi-Strategy Advisers reported no remaining Integra LifeSciences position as of Q1 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 11,621 Integra LifeSciences shares in Q1 2014, an estimated $227K.
Weiss Multi-Strategy Advisers first reported a position in Integra LifeSciences in Q4 2013 and held it in 1 quarter.
Weiss Multi-Strategy Advisers's Integra LifeSciences position peaked at $227K in Q4 2013.
144 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.